Aurinia Pharmaceuticals Inc (AUPH)
5.10
-0.07
(-1.35%)
USD |
NASDAQ |
May 03, 16:00
5.095
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Investing (Quarterly): -6.257M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.257M |
| September 30, 2023 | -19.70M |
| June 30, 2023 | -5.608M |
| March 31, 2023 | 24.86M |
| December 31, 2022 | -3.018M |
| September 30, 2022 | -50.22M |
| June 30, 2022 | 45.62M |
| March 31, 2022 | -53.02M |
| December 31, 2021 | -5.487M |
| September 30, 2021 | -32.81M |
| June 30, 2021 | 1.67M |
| March 31, 2021 | -67.25M |
| December 31, 2020 | 19.15M |
| September 30, 2020 | -144.50M |
| June 30, 2020 | -20.71M |
| March 31, 2020 | -12.13M |
| December 31, 2019 | -0.029M |
| September 30, 2019 | -0.03M |
| June 30, 2019 | 3.952M |
| March 31, 2019 | 3.89M |
| December 31, 2018 | 16.07M |
| September 30, 2018 | -6.085M |
| June 30, 2018 | 9.97M |
| March 31, 2018 | -20.02M |
| December 31, 2017 | 86.96M |
| Date | Value |
|---|---|
| September 30, 2017 | -84.89M |
| June 30, 2017 | -7.025M |
| March 31, 2017 | -3.048M |
| December 31, 2016 | 3.036M |
| September 30, 2016 | -0.039M |
| June 30, 2016 | 4.038M |
| March 31, 2016 | 2.956M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.019M |
| June 30, 2015 | -0.031M |
| March 31, 2015 | -0.011M |
| December 31, 2014 | -0.02M |
| September 30, 2014 | -10.01M |
| June 30, 2014 | -0.047M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.019M |
| September 30, 2013 | -0.03M |
| June 30, 2013 | -0.047M |
| March 31, 2013 | 0.06M |
| December 31, 2012 | -0.0098M |
| September 30, 2012 | -0.0036M |
| June 30, 2012 | 0.8423M |
| March 31, 2012 | -0.86M |
| December 31, 2011 | -0.085M |
| September 30, 2011 | 0.0534M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-144.50M
Minimum
Sep 2020
45.62M
Maximum
Jun 2022
-17.13M
Average
-5.608M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Lexaria Bioscience Corp | -0.057M |
| Acasti Pharma Inc | -6.554M |
| Edesa Biotech Inc | 0.00 |
| Xenon Pharmaceuticals Inc | -239.73M |
| ESSA Pharma Inc | 8.232M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 14.31M |
| Cash from Financing (Quarterly) | -5.577M |
| Free Cash Flow | -34.18M |
| Free Cash Flow Per Share (Quarterly) | 0.0992 |
| Free Cash Flow to Equity (Quarterly) | 14.25M |
| Free Cash Flow to Firm (Quarterly) | 14.25M |
| Free Cash Flow Yield | -4.69% |